stockrowAtriCure, Inc.
ATRC Healthcare Medical Instruments & Supplies
AtriCure, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $534.5 million, up 14.9% from fiscal 2024.
- Revenue
- +15.0%
- EPS
- +1,583.9%
- Free cash flow
- −0.73%
- Total debt
- −17.3%
Quarter to September 2026, against a year earlier
Follow ATRC
Alert me
AtriCure, Inc. (ATRC) EV/FCF
As of 5 November 2026, AtriCure, Inc. (ATRC) trades at a EV/FCF of 125×. Over the past ten years it has ranged from −379× (August 2025) to 659× (December 2025); the current reading is higher than 98% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 99.3× | — |
| FY2024 | −47.7× | — |
| FY2023 | −42.1× | — |
| FY2022 | −51.3× | — |
| FY2021 | −131× | — |
| FY2020 | −86.2× | — |
| FY2019 | −43.4× | — |
| FY2018 | −93.4× | — |
| FY2017 | −39.3× | — |
| FY2016 | −26.4× | — |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Sep 2026 | 115× | 107.12% |
| Jun 2026 | 55.6× | (0.77%) |
| Mar 2026 | 56.1× | (43.55%) |
| Dec 2025 | 99.3× | (81.78%) |
| 43 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| STVN Stevanato Group S.p.A. compare | −453× |
| PLSE Pulse Biosciences, Inc compare | −17.8× |
| MMED MiniMed Group, Inc. compare | −10.9× |
| NVST Envista Holdings Corporation compare | 18.0× |
| MMSI Merit Medical Systems, Inc. compare | 24.7× |
| ICUI ICU Medical, Inc. compare | 25.5× |
| XRAY DENTSPLY SIRONA Inc. compare | 40.0× |
| ATRC AtriCure, Inc. | 125× |
| WRBY Warby Parker Inc. compare | 139× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on ATRC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement